Research has also reported elevated SUCNR1 expression in the liver during non-alcoholic steatohepatitis (NASH) in both animal models [12, 26] and humans [12, 59], hinting that SUCNR1 expression might serve as a valuable prognostic marker for NASH [12]. This evidence concerns the gene SUCNR1 and metabolic dysfunction-associated steatohepatitis.